1-4 of 4
Lori Rink
Close
Sort by
Journal Articles

Enhanced phosphorylation of Nbs1, a member of DNA repair/checkpoint complex Mre11-RAD50-Nbs1, can be targeted to increase the efficacy of imatinib mesylate against BCR/ABL-positive leukemia cells

Lori Rink, Artur Slupianek, Tomasz Stoklosa, Margaret Nieborowska-Skorska, Katarzyna Urbanska, Ilona Seferynska, Krzysztof Reiss, Tomasz Skorski
Journal: Blood
Blood (2007) 110 (2): 651–660.
https://doi.org/10.1182/blood-2006-08-042630
Published: 2007
Includes: Supplemental data
Journal Articles

Enhanced Phosphorylation of Nbs1, a Member of DNA Repair/Checkpoint Complex RAD50-Mre11-Nbs1, Can Be Targeted Simultaneously with BCR/ABL Kinase To Eliminate Leukemia Cells.

Lori Rink, PhD, Tomasz Stoklosa, MD, PhD, Margaret Nieborowska-Skorska, MD, PhD, Artur Slupianek, PhD, Ilona Seferynska, MD, Tomasz Skorski, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 2127.
https://doi.org/10.1182/blood.V108.11.2127.2127
Published: 2006
Journal Articles

Enhanced Phosphorylation of Nbs1, a Member of the DNA Repair/Checkpoint Activation Complex Rad50/Mre11/Nbs1, Prolongs Cell Cycle S Phase and Contributes to Drug Resistance in BCR/ABL-Positive Leukemias.

Lori Rink, Tomasz Stoklosa, MD, PhD, Tomasz Skorski, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 2867.
https://doi.org/10.1182/blood.V106.11.2867.2867
Published: 2005
Journal Articles

ATR-Chk1 Axis Is Activated, but the Function of Chk1 Is Disrupted in BCR/ABL Leukemia Cells Responding to DNA Damage.

Margaret Nieborowska, MD, PhD, Tomasz Stoklosa, MD, PhD, Mandrita Datta, Agnieszka Czechowska, Lori Rink, Janusz Blasiak, PhD, Tomasz Skorski, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 2883.
https://doi.org/10.1182/blood.V106.11.2883.2883
Published: 2005